| Due Diligence for Asset Managers |
|---|
|
Analyze the public filings of asset managers Dive into the EDGAR, IAPD, CAFR source data |
|
⚲
|
| Keyboard |
| Cellect Biotechnology Ltd | |
|---|---|
| Ticker | QNRX |
| CIK # | 0001671502 |
| CUSIP | 74907L300 |
| Sector | Life Sciences - Surgical & Medical Instruments & Apparatus |
| Address | 23 Hata'As Street, Kfar Saba, 44425 |
| Source | [EDGAR] |
| Reg D Offering (Form D) | Filed | Raised | Terms |
|---|---|---|---|
| Quoin Pharmaceuticals Ltd | 2025-10-23 | 105.3 M | Exemption: 506(b) · Duration: One year or less · Commission: $1,227,995 · Revenue: Decline to Disclose |
| Cellect Biotechnology Ltd | 2018-02-09 | 4.0 M | Exemption: 506(b) · Duration: One year or less · Commission: $280,000 · Revenue: No Revenues |
| CIK | Filing | 2011 - 2026 |
|---|---|---|
| [0001671502] | 10-K | |
| [0001671502] | 10-Q | |
| [0001671502] | 3 | |
| [0001671502] | 4 | |
| [0001671502] | 6-K | |
| [0001671502] | 8-K | |
| [0001671502] | D | |
| [0001671502] | SC 13D | |
| [0001671502] | SC 13G |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
Cooper Joseph Patrick
Share Option (Right to Buy) · derivative
|
2026-02-04 | Grant | 8,141 | $0.00 | |
|
Culverwell Anthony James
Share Option (Right to Buy) · derivative
|
2026-02-04 | Grant | 21,709 | $0.00 | |
|
Myers Michael
Share Option (Right to Buy) · derivative
|
2026-02-04 | Grant | 318,750 | $0.00 | |
|
Carter Denise P
Share Option (Right to Buy) · derivative
|
2026-02-04 | Grant | 318,750 | $0.00 | |
|
Lawlor Sally Bridget
Share Option (Right to Buy) · derivative
|
2026-02-04 | Grant | 85,250 | $0.00 | |
|
Langer Dennis
Share Option (Right to Buy) · derivative
|
2026-02-04 | Grant | 21,709 | $0.00 | |
|
Sember Michael T
Share Option (Right to Buy) · derivative
|
2026-02-04 | Grant | 8,141 | $0.00 | |
|
Leong Natalie Ee Mun
Share Option (Right to Buy) · derivative
|
2026-02-04 | Grant | 12,211 | $0.00 | |
|
Lawlor Sally Bridget
Share Option (Right to Buy) · derivative
|
2025-12-01 | Grant | 10,330 | $0.00 | |
|
Langer Dennis
Series K Warrants (Right to Buy) · derivative
|
2025-10-14 | Buy | 15,152 | ||
|
Langer Dennis
ADSs
|
2025-10-14 | Buy | 15,152 | $8.49 | 128,640 |
|
Langer Dennis
Series H Warrants (Right to Buy) · derivative
|
2025-10-14 | Buy | 15,152 | ||
|
Langer Dennis
Series I Warrants (Right to Buy) · derivative
|
2025-10-14 | Buy | 15,152 | ||
|
Langer Dennis
Series J Warrants (Right to Buy) · derivative
|
2025-10-14 | Buy | 15,152 | ||
|
Share Option (Right to Buy) · derivative
|
2025-08-21 | Grant | 4,105 | $0.00 | |
|
Share Option (Right to Buy) · derivative
|
2025-08-21 | Grant | 13,682 | $0.00 | |
|
Share Option (Right to Buy) · derivative
|
2025-08-21 | Grant | 13,682 | $0.00 | |
|
Share Option (Right to Buy) · derivative
|
2025-05-29 | Grant | 42,857 | $0.00 | |
|
Share Option (Right to Buy) · derivative
|
2025-05-29 | Grant | 42,857 | $0.00 | |
|
Culverwell Anthony James
Share Option (Right to Buy) · derivative
|
2025-05-29 | Grant | 7,760 | $0.00 | |
| showing 20 of 68 most recent transactions | |||||
| 13F Ownership Over Time | Holders | Shares Held |
|---|---|---|
| 2026-03-31 | 21 | 1,184,721 |
| 2025-12-31 | 18 | 842,827 |
| 2025-09-30 | 4 | 1,491 |
| 2025-06-30 | 7 | 2,537 |
| 2025-03-31 | 11 | 401,630 |
| 2024-12-31 | 15 | 1,546,454 |
| 2024-09-30 | 8 | 165,726 |
| 2024-06-30 | 11 | 220,718 |
| 2024-03-31 | 9 | 194,796 |
| 2023-12-31 | 4 | 22,047 |
| 2023-09-30 | 4 | 1,735 |
| 2023-06-30 | 3 | 48,933 |
| Form 13F Holdings | ||||
|---|---|---|---|---|
| Firm | Period | DFND | Voting | Shares |
| Gamma Investing LLC | [2026-06-30] | DFND | 439 | 439 | Prev | Page 1 | Next |